Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
$683M |
| 2 |
RTX Corp
RTX
|
$615M |
| 3 |
Meta Platforms (Facebook)
META
|
$553M |
| 4 |
Eli Lilly
LLY
|
$389M |
| 5 |
T-Mobile US
TMUS
|
$386M |
Top Sells
| 1 |
Amazon
AMZN
|
$945M |
| 2 |
Microsoft
MSFT
|
$572M |
| 3 |
Gilead Sciences
GILD
|
$467M |
| 4 |
Merck
MRK
|
$368M |
| 5 |
Intel
INTC
|
$361M |
Sector Composition
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Accenture
ACN
$162B
| $1B | 0.41% | 4,662,413 -121,995 | -3% | -$26.2M |
|
52
Broadcom
AVGO
$1.4T
| $995M | 0.41% | 3,152,947 +129,659 | +4% | +$40.9M |
|
53
Zoetis
ZTS
$69.3B
| $993M | 0.4% | 7,248,217 +341,152 | +5% | +$46.8M |
|
54
Morgan Stanley
MS
$240B
| $958M | 0.39% | 19,840,989 +1,868,327 | +10% | +$90.2M |
|
55
ServiceNow
NOW
$190B
| $955M | 0.39% | 2,357,304 -294,851 | -11% | -$119M |
|
56
Citigroup
C
$178B
| $928M | 0.38% | 18,169,415 +956,556 | +6% | +$48.9M |
|
57
Abbott
ABT
$231B
| $923M | 0.38% | 10,100,593 +403,277 | +4% | +$36.9M |
|
58
Amgen
AMGN
$155B
| $920M | 0.37% | 3,901,641 +166,076 | +4% | +$39.2M |
|
59
Texas Instruments
TXN
$184B
| $915M | 0.37% | 7,208,994 -2,541,939 | -26% | -$323M |
|
60
Applied Materials
AMAT
$128B
| $908M | 0.37% | 15,025,978 +47,990 | +0.3% | +$2.9M |
|
61
Equinix
EQIX
$76.9B
| $897M | 0.37% | 1,277,695 +65,826 | +5% | +$46.2M |
|
|
62
RTX Corp
RTX
$212B
| $894M | 0.36% | 14,506,135 +9,973,430 | +220% | +$615M |
|
63
Qualcomm
QCOM
$173B
| $870M | 0.35% | 9,535,939 +1,870,075 | +24% | +$171M |
|
64
NextEra Energy, Inc.
NEE
$148B
| $857M | 0.35% | 3,570,244 -542,884 | -13% | -$130M |
|
65
Cigna
CI
$80.3B
| $795M | 0.32% | 4,238,744 +183,589 | +5% | +$34.5M |
|
66
Booking.com
BKNG
$181B
| $795M | 0.32% | 499,434 +233,397 | +88% | +$372M |
|
67
Philip Morris
PM
$260B
| $781M | 0.32% | 11,144,203 -337,791 | -3% | -$23.7M |
|
68
Bristol-Myers Squibb
BMY
$96B
| $778M | 0.32% | 13,226,824 -4,992,608 | -27% | -$294M |
|
69
Boston Scientific
BSX
$156B
| $747M | 0.3% | 21,275,455 +733,415 | +4% | +$25.8M |
|
70
Illumina
ILMN
$15.8B
| $742M | 0.3% | 2,003,459 -174,347 | -8% | -$64.6M |
|
71
American Express
AXP
$231B
| $736M | 0.3% | 7,733,198 -1,449,412 | -16% | -$138M |
|
72
Exxon Mobil
XOM
$487B
| $734M | 0.3% | 16,407,318 -1,600,270 | -9% | -$71.6M |
|
73
NXP Semiconductors
NXPI
$59.2B
| $695M | 0.28% | 6,090,780 +3,070,819 | +102% | +$350M |
|
74
Thermo Fisher Scientific
TMO
$186B
| $672M | 0.27% | 1,855,161 -45,351 | -2% | -$16.4M |
|
75
Fidelity National Information Services
FIS
$36.5B
| $658M | 0.27% | 4,905,482 -1,590,437 | -24% | -$213M |
|